At IBM, we do more than work. We create. We create as technologists, developers, and engineers. We create with our partners. We create with our competitors. If you're searching for ways to make the world work better through technology and infrastructure, software and consulting, then we want to work with you.
We're here to help every creator turn their "what if" into what is. Let's create something that will change everything.
Tempus is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. With one of the world’s largest libraries of multimodal data, and an operating system to make that data accessible and useful, Tempus provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. The goal is for each patient to benefit from the treatment of others who came before by providing physicians with tools that learn as the company gathers more data.
For more information, visit tempus.com.
Freenome is a personalized cancer detection company using an AI-driven multiomics platform to develop and optimize single- and multi-cancer blood tests that can identify cancer in its earliest, most treatable stages.
We operate an expansive, CLIA-certified clinical and research lab in our headquarters in Brisbane, CA. Our development of SimpleScreen CRC (approved by the FDA in July 2026) for colorectal cancer screening, SimpleScreen Lung (launched as a laboratory-developed test in October 2026) and a pipeline of tests for additional indications is designed to increase cancer screening participation among millions of at-risk individuals.
Freenome went public in July 2026, entering Nasdaq under the ticker symbol “FRNM” and raising gross proceeds of $310 million. The company has a licensing agreement with Abbott to lead the U.S. commercialization of SimpleScreen CRC, as well as a strategic collaboration partnership with Roche for R&D and ex-U.S. commercialization of our screening technology.
A ‘Freenomer’ is a mission-driven employee who is fueled by the opportunity to make a positive impact on patients' lives, who thrives in a culture of respect and cross-functional collaboration, and whose work makes a significant impact on the company and their career.